CN103768246A - Traditional Chinese medicine preparation - Google Patents

Traditional Chinese medicine preparation Download PDF

Info

Publication number
CN103768246A
CN103768246A CN201210414391.2A CN201210414391A CN103768246A CN 103768246 A CN103768246 A CN 103768246A CN 201210414391 A CN201210414391 A CN 201210414391A CN 103768246 A CN103768246 A CN 103768246A
Authority
CN
China
Prior art keywords
extract
chinese medicine
medicine preparation
extractive
traditional chinese
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201210414391.2A
Other languages
Chinese (zh)
Inventor
王荣军
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SUZHOU YANGHAI ELECTRONICS CO Ltd
Original Assignee
SUZHOU YANGHAI ELECTRONICS CO Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SUZHOU YANGHAI ELECTRONICS CO Ltd filed Critical SUZHOU YANGHAI ELECTRONICS CO Ltd
Priority to CN201210414391.2A priority Critical patent/CN103768246A/en
Publication of CN103768246A publication Critical patent/CN103768246A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a traditional Chinese medicine preparation which comprises the following active constituents in percentage by weight: 20 to 40% of a ginkgo biloba extractive, 20 to 40% of a panax quinquefolium extractive, 15 to 30% of a lycium barbarum L. extractive, 15 to 30% of an astragalus membranaceus extractive, 2 to 10% of ferrous lactate and the balance of an auxiliary material. According to the invention, traditional Chinese medicines such as ginkgo leaf, panax quinquefolium, lycium barbarum L., astragalus membranaceus are performed scientific compatibility with the ferrous lactate, the fatigue-resistant effect is obviously improved, and obvious side effects are avoided.

Description

Chinese medicine preparation
Technical field
The present invention relates to health food technology field, what be specifically related to is a kind of Chinese medicine preparation for alleviating physical fatigue.
Background technology
Modern medicine thinks that fatigue is that body transfinites and the function that causes reduces and occur that the state of body discomfort, main manifestations are tired sleepy, can occur degradation simultaneous phenomenon under dizziness, forgetful, sleep quality.The factor relations such as tired generation and energy substance consumption, metabolite accumulation, homeostasis sexual maladjustment, free radical impact are close.Along with the reinforcement of people's health care consciousness, various anti-fatigue products arise at the historic moment, wherein Chinese medicine series products natural with it, safely, the advantage such as have no side effect, day by day receive people's concern, as aweto capsule, Radix Panacis Quinquefolii sheet etc.Therefore, exploitation has the health food of the alleviating physical fatigue of tcm characteristic, not only can make up the deficiency of modern medicine in treatment, the advantage of performance Chinese medicine, and also its suitable crowd's scope is wide, and the market demand is large, has wide market prospect.
Summary of the invention
Object of the present invention is just to provide a kind of Chinese medicine preparation for alleviating physical fatigue.Not only dialectical prescription, the fundamentally root of relieving fatigue, also combines nutrient, hardening agent homenergic material, to promote antisecosis.
In order to realize the object of the invention, the active component and the weight content thereof that form this health food are: Folium Ginkgo extract 20-40%, Radix Panacis Quinquefolii extract 20-40%, wolfberry fruit extract 15-30%, Radix Astragali extract 15-30%, ferrous lactate 2-10%, remaining is adjuvant.
In the present invention, Folium Ginkgo extract is no less than 5% containing terpene lactone; Radix Panacis Quinquefolii extract total saponin content is no less than 5%; Wolfberry fruit extract is no less than 10% containing lycium barbarum polysaccharide; Radix Astragali extract is no less than 20% containing astragalus polysaccharides.
Compared with prior art, advantage of the present invention is: dialectical prescription in conjunction with nutrient, curative effect is clear and definite.
Folium Ginkgo: be the leaf of ginkgo, main component is ginkgetin.Nature and flavor hardship, puckery, flat.Function is astringed the lung and is relievingd asthma, promoting blood circulation and stopping pain.For cough and asthma due to lung deficiency, and hyperlipidemia, hypertension, angina pectoris, cerebral vasospasm etc.Decoction 5~10g, or make tablet, injection.
Radix Panacis Quinquefolii: be the root of Araliaceae Radix Panacis Quinquefolii Panax quinquefolium L..Main product is in the U.S., Canada.Also there is cultivation on the ground such as China Beijing, Jilin, Liaoning.Excavate the growth root of 3~6 years autumn, section is raw to be used.Radix Panacis Quinquefolii has Antishock function, can obviously improve hemorrhagic shock rats survival rate; Brain is had to sedation, vital center is had to moderate excitation; Also have anti-hypoxia, resist myocardial ischemia, anti-cardiac muscle oxidation, increase myocardial contraction, arrhythmia, resisting fatigue, anti-stress, convulsion, blood sugar lowering, hemostasis and antidiuretic activity.
Fructus Lycii: be the mature fruit of plant of Solanaceae lycium barbarum Lycium barbarum L..Main product in Ningxia, the ground such as Gansu, Xinjiang.Two autumn of autumn in summer gathers when fruit is orange red, dry in the air to rhicnosis, then shine to crust stiff, sarcocarp softness, raw using.Fructus Lycii has facilitation to immunity, has immunoregulation effect simultaneously; Can improve plasma testosterone level, play strong effect; Hemopoietic function is had to facilitation; Normal healthy people is also had to remarkable effect in increasing leukocyte; Also have defying age, mutation, antitumor, blood fat reducing, protect the liver and anti-fatty liver, blood sugar lowering, hypotensive activity.
The Radix Astragali: be the root of leguminous plant Radix Astagali Asytagalus memeranaceus (Fisch.) Bge.var.mongholicus (Bge.) Hsiao or Radix Astragali A.membrabaceus (Fisch.) Bge..Main product in the Inner Mongol, the ground such as Shanxi, Heilungkiang.Two seasons of spring and autumn excavate, and remove fibrous root and root head, dry section, raw using or processed with honey use.The Radix Astragali can promote the renewal of organism metabolism, resisting fatigue, promotion serum and hepatic protein; There is obvious diuresis, can eliminate Jishengshenqiwan urine protein; Can improve anemia animal phenomenon; The hypoglycemia that can raise, reduces hyperglycemia; Can excitedly breathe; Can strengthen and regulate body's immunity, interferon system is had to facilitation, can improve the premunition of body; The multiple viral institute such as infected by influenza cytopathogenic effect has slight inhibitory action, and influenza virus infected has protective effect; There is antibacterial action more widely; The Radix Astragali, in cell culture, can make cell number showed increased, and Growth of Cells is vigorous, life; Can strengthen myocardial contraction, protection cardiovascular system, anti-arrhythmia, coronary artery dilator and peripheral blood vessel, reduce blood pressure, and can reduce platelet adhesion power, reduces thrombosis; Also have blood fat reducing, defying age, anti-hypoxia, radioprotective, the effect such as protect the liver.
Ferrous lactate: this product is ferrum element supplement.Ferrum is the chief component composition of hemoglobin and Myoglobin.Hemoglobin is the person that mainly takes oxygen in erythrocyte, and Myoglobin is the position that muscle cell is stored oxygen, and the needs of oxygen are provided during for muscular movement.With tricarboxylic cycle relevant most of enzymes and the equal iron content of the factor, or only in the time that existing, ferrum just plays a role.Body lacks ferrum, can cause and be short of physical strength etc.
The specific embodiment
The preparation of embodiment 1 capsule of the present invention
Folium Ginkgo extract 20%, Radix Panacis Quinquefolii extract 20%, wolfberry fruit extract 20%, Radix Astragali extract 30%, ferrous lactate 10%, remaining is adjuvant.
The preparation of embodiment 2 tablets of the present invention
Folium Ginkgo extract 40%, Radix Panacis Quinquefolii extract 20%, wolfberry fruit extract 23%, Radix Astragali extract 15%, ferrous lactate 2%.Raw material is added to right amount of auxiliary materials, tabletting.
The preparation of embodiment 3 capsules of the present invention
Folium Ginkgo extract 30%, Radix Panacis Quinquefolii extract 40%, wolfberry fruit extract 15%, Radix Astragali extract 15%, ferrous lactate 10%, remaining is adjuvant.

Claims (2)

1. a Chinese medicine preparation, the active component and the weight content thereof that form this Chinese medicine preparation are: Folium Ginkgo extract 20-40%, Radix Panacis Quinquefolii extract 20-40%, wolfberry fruit extract 15-30%, Radix Astragali extract 15-30%, ferrous lactate 2-10%, remaining is adjuvant.
2. Chinese medicine preparation as claimed in claim 1, is characterized in that, Folium Ginkgo extract is no less than 5% containing terpene lactone; Radix Panacis Quinquefolii extract total saponin content is no less than 5%; Wolfberry fruit extract is no less than 10% containing lycium barbarum polysaccharide; Radix Astragali extract is no less than 20% containing astragalus polysaccharides.
CN201210414391.2A 2012-10-26 2012-10-26 Traditional Chinese medicine preparation Pending CN103768246A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201210414391.2A CN103768246A (en) 2012-10-26 2012-10-26 Traditional Chinese medicine preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201210414391.2A CN103768246A (en) 2012-10-26 2012-10-26 Traditional Chinese medicine preparation

Publications (1)

Publication Number Publication Date
CN103768246A true CN103768246A (en) 2014-05-07

Family

ID=50561306

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201210414391.2A Pending CN103768246A (en) 2012-10-26 2012-10-26 Traditional Chinese medicine preparation

Country Status (1)

Country Link
CN (1) CN103768246A (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101703623A (en) * 2009-11-12 2010-05-12 西安斯强实业有限公司 Capsule with effect of relieving physical fatigue
CN101756185A (en) * 2008-10-22 2010-06-30 于树丽 American ginseng astragalus buccal tablet
CN101816355A (en) * 2010-02-22 2010-09-01 李宏良 Anti-fatigue alternative tea and preparation method thereof
CN102362881A (en) * 2011-10-31 2012-02-29 广西亿康药业股份有限公司 Method for preparing ginkgo and American ginseng preparation

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101756185A (en) * 2008-10-22 2010-06-30 于树丽 American ginseng astragalus buccal tablet
CN101703623A (en) * 2009-11-12 2010-05-12 西安斯强实业有限公司 Capsule with effect of relieving physical fatigue
CN101816355A (en) * 2010-02-22 2010-09-01 李宏良 Anti-fatigue alternative tea and preparation method thereof
CN102362881A (en) * 2011-10-31 2012-02-29 广西亿康药业股份有限公司 Method for preparing ginkgo and American ginseng preparation

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
明月: ""缓解疲劳食物"", 《中国保健营养》 *

Similar Documents

Publication Publication Date Title
CN101703623A (en) Capsule with effect of relieving physical fatigue
WO2022062716A1 (en) Composition having function of nourishing yin and tonifying kidney, and preparation method therefor and use thereof
CN101972353A (en) Medicine composition for preventing and treating heart cerebrovascular diseases
CN102948748A (en) Anti-fatigue health care product
CN104083636A (en) Immunity enhancement dendrobium officinale composition and preparation method thereof
CN103766885A (en) Health food for alleviating physical fatigue
CN102640826B (en) Dietary blood-nourishing tea granules for improving alimentary anemia
CN103564087A (en) Cordyceps militaris tea
CN103766888A (en) Preparation containing American ginseng extract
CN103800407A (en) Health-care product composition
CN102669340B (en) Food blood nourishing tea granule for relieving alimentary anemia
CN102600299A (en) Compound granules for improving sleeping and preparation method thereof
CN109674885A (en) A kind of maintenance prescription for mental worker or frequent alcohol user
CN103735871A (en) Chinese medicinal composition for treating neurasthenia and preparation method thereof
CN103768246A (en) Traditional Chinese medicine preparation
CN1686396A (en) Health care product having anoxia tolerance function
CN103800548A (en) Compound traditional chinese medicine
CN103798755A (en) Anti-fatigue capsule
CN103798771A (en) Traditional Chinese medicine extract-containing compound preparation
CN103766884A (en) Novel composite preparation agent
CN103766887A (en) Preparation comprising astragalus mongholicus extract
CN103798772A (en) Health-care product composition
CN103798754A (en) Traditional chinese medicine composition
CN103798758A (en) Preparation containing ginkgo leaf extract
CN108079275A (en) A kind of health Chinese medicine composition for treating hypertension and preparation method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20140507